El interés en corto de Baird Medical Investment da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Baird Medical Investment. Los datos de interés en corto se actualizan cada dos semanas.

Baird Medical Investment (NASDAQ:BDMD) Bolsa, Informe de interés en corto

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Descubre las acciones que lideran el premercado con sorprendentes subidas y caídas. INNOVATE y más protagonistas hoy.

Las acciones de INNOVATE (VATE) cotizan un 19% más alto; 20 acciones que se mueven en el premercado de EE.UU.

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment Holdings Ltd

Baird Medical Investment Holdings Ltd - Warrant

Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) released preliminary financial results for the first half of 2025 ahead of the company's second quarter earnings call on July 29.
Check out the current price of<a href="https://benzinga.com/quote/stla"> STLA stock here</a>.
What Happened: The automaker expects Euro 2.3 billion (roughly $2.68 billion) net loss in the first half of the year, the company said in an official press release published on Monday.
The company shipped 1.4 million units globally in the first half of the year, a 6% year-over-year decline in shipments due to President Donald Trump's tariffs on the auto industry, Stellantis said.
North American shipments declined 25% year-over-year. Stellantis said that Trump's tariffs and lower fleet sales led to reduced manufacturing and imports, which were one of the main factors driving the decline in shipments. Total sales were down 10%, Stellantis said.
Why It Matters: The news comes as Stellantis recently announced it would be abandoning the development of <a href="https://www.benzinga.com/markets/tech/25/07/46437558/stellantis-abandons-hydrogen-vehicle-plans-citing-weak-infrastructure-and-incentives-report">Hydrogen fuel cell technology</a>, citing a lack of mid-term growth in the sector and incentives for customers.
The company had earlier dropped its yearly earnings guidance, citing uncertainty caused by Trump's 25% tariffs on the auto industry and named veteran Antonio Filosa <a href="https://www.benzinga.com/markets/eurozone/25/05/45638939/stellantis-names-antonio-filosa-ceo-amid-uncertainty-over-trumps-50-eu-tariff-threat">as new CEO</a>.
Tariffs had also caused Stellantis to move some production of its Pickup trucks <a href="https://www.benzinga.com/markets/25/05/45133236/chrysler-jeep-owner-stellantis-to-move-some-auto-production-into-the-us-to-avoid-tariffs">away from Mexico</a> and into its Michigan manufacturing facility in the U.S. in a bid to offset some of the tariffs.&nbsp;&nbsp;
Elsewhere, Trump had hinted that he <a href="https://www.benzinga.com/markets/tech/25/06/45919154/trump-says-he-may-hike-auto-tariffs-again-to-boost-domestic-production-the-higher-you-go-they-build-a-plant-here">could hike automotive tariffs again</a> in a bid to boost domestic production efforts in the U.S. during a White House press event. "The higher you go, the more likely it is they build a plant here," Trump said at the event.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="208" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21061528/STLA-jUl-212025-1024x208.jpg" alt="" class="wp-image-993400" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21061528/STLA-jUl-212025-1024x208.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21061528/STLA-jUl-212025-300x61.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21061528/STLA-jUl-212025-768x156.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21061528/STLA-jUl-212025-1536x311.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21061528/STLA-jUl-212025.jpg 1549w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Stellantis offers poor Momentum and Quality and offers satisfactory Growth, but scores well on the Value metric. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46436042/ford-responds-to-trumps-ev-policy-shift-with-push-for-affordable-electric-models">Ford Responds To Trump's EV Policy Shift With Push For Affordable Electric Models</a></li>
</ul>
Photo courtesy: rikstock / Shutterstock.com

STLA

Chrysler, Jeep Parent Company Stellantis Expects $2.7 Billion Net Loss In First Half Of 2025 As Trump Tariffs Cause Uncertainty

HC Wainwright &amp; Co. analyst Scott Buck maintains BlackSky Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) with a Buy and raises the price target from $20 to $28.

Price Target

Analyst Ratings

BlackSky Technology Inc. Class A Common Stock

BKSY

HC Wainwright & Co. Maintains Buy on BlackSky Technology, Raises Price Target to $28

RBC Capital analyst Mike Dahl initiates coverage on QXO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NYSE">QXO</a>) with a Outperform rating and announces Price Target of $33.

Initiation

RBC Capital Initiates Coverage On QXO with Outperform Rating, Announces Price Target of $33

JP Morgan analyst Bill Peterson maintains MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) with a Neutral and raises the price target from $18 to $64.

JP Morgan Maintains Neutral on MP Materials, Raises Price Target to $64

Keefe, Bruyette &amp; Woods analyst Christopher O'Connell maintains Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) with a Outperform and raises the price target from $81 to $95.

Keefe, Bruyette & Woods Maintains Outperform on Metropolitan Bank Holding, Raises Price Target to $95

Orano Canada Inc. ("Orano Canada"), the 77.5% owner and operator of the MLJV, completed a 6,400-metre exploration drilling program at McClean South during the first half of 2025. The drill program was highlighted by multiple notable high-grade intersections at the 8C mineralized pod:
<ul>
<li>MCS-77 intersected 7.51% eU3O8 over 5.4 metres from 165.7 to 171.1 metres (including 10.88% eU3O8 over 3.7 metres),</li>
<li>MCS-80 intersected 3.5% eU3O8 over 11.2 metres from 156.7 to 167.9 metres (including 5.81% eU3O8 over 6.5 metres), and</li>
<li>MCS-84 intersected 1.72% eU3O8 over 20.6 metres from 150.6 to 170.7 metres (including 4.43% eU3O8 over 4.0 metres)</li>
</ul>

Commodities

Denison Announces New Intercepts Of Shallow High-Grade Uranium Mineralization At McClean South Zone

NUVL

Nuvalent Announces First Patient Dosed In ALKAZAR, Phase 3 Randomized, Controlled Trial Evaluating Neladalkib For TKI-Naïve Patients With Advanced ALK-Positive NSCLC, Versus ALECENSA

NanoViricides, Inc., a publicly traded company (NYSE Amer.:<a href="https://pr.report/cgtw"> NNVC</a> ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced that it has achieved significant success in developing a drug against Measles.
Strong antiviral effectiveness against Measles virus was found for NV-387, the Company's broad-spectrum drug candidate, in a humanized animal model study.
"NV-387 is on its way to become the very first drug to treat Measles," said Anil R. Diwan, PhD, adding, "Measles cases are skyrocketing globally, and the world needs a drug."
In a lethal animal model of respiratory infection with Measles virus, NV-387 increased survival of animals to 17 days on average compared to 7.4 days in untreated animals, an increase of 130%. There were no signs of toxicity from the drug NV-387. Additionally, dose-dependent increase in survival was observed.
NV-387 is a clinical stage broad-spectrum antiviral drug that is designed to act as a decoy of a cell, attacking the virus by presenting to it the very features that the virus requires for binding to the cell, and upon binding, destroying the virus particle so it cannot infect. Over 90-95% of human pathogenic viruses require the sulfated proteoglycan feature that NV-387 presents to the virus.
The Company has conducted an animal trial to evaluate certain drug candidates in a lethal animal infection model of measles virus. The Company secured specially modified mice that bear the human form of CD150/SLAM protein that the Measles virus requires to enter cells for this study. Measles does not infect mice natively, so humanized mice were required for this study.
The Company hypothesized that NV-387 could be effective against Measles because NV-387 was previously found to completely cure RSV lung infection in a lethal animal model. Both RSV and Measles virus belong to paramyxoviruses family. Additionally, both viruses are known to use heparan sulfate proteoglycan (HSPG) as the initial attachment point before causing cellular infection. However, the mode of actual infection between these viruses differs drastically. RSV primarily infects lung epithelial cells, whereas Measles virus infects h-CD150 bearing immune system cells. The animal study validated the Company's hypothesis.

NNVC

NanoViricides Reports Breakthrough Measles Drug NV-387 Boosts Survival by 130% in Animal Study

Elon Musk&#8216;s Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is facing safety concerns as it expands its autonomous ride-hailing service in Austin, Texas, spurring doubts if the robotaxi service is scalable.
What Happened: Joe Tegtmeyer, a Tesla owner, had a close call when his autonomous vehicle tried to cross a railroad illegally. Despite the incident, Tegtmeyer supports the idea of more Tesla vehicles on the road to decrease wait times, <a href="https://fortune.com/2025/07/20/elon-musk-tesla-robotaxi-service-austin-scaling-earnings-car-sales/">reported </a>Fortune. 
Check out the current price of&nbsp;<a href="https://benzinga.com/quote/TSLA" target="_blank" rel="noreferrer noopener">TSLA stock here</a>.
Elias Martinez, an early Full Self-Driving beta tester, voiced concerns about the software&#8217;s readiness. He contends that the technology &#8220;nowhere near robust&#8221; to accommodate the 10,000 cars Musk suggested were theoretically feasible. 
Martinez, who also runs the FSD Community Tracker, a platform for data collection and analysis of Tesla&#8217;s self-driving technology, stated that the more cars added, the higher the risk of a collision.&nbsp;He asserted that for any robotaxi service, including Tesla's, to scale safely, it must operate with near-perfect reliability.
He noted that even with substantial improvements over the past four years, the software continues to display serious problems, including running red lights and driving on the wrong side of the road.
He believes Tesla prioritized meeting Musk's June launch deadline over refining the technology, as falling EV demand and the Cybertruck's flop left the CEO needing to reassure investors.
"This feels like a distraction from the declining sales numbers," Martinez stated, adding "Elon is gambling."
See Also: <a href="https://benzinga.com/crypto/cryptocurrency/25/07/46500411/dogecoin-surges-14-in-a-week-is-doge-the-next-treasury-asset-boom" target="_blank" rel="noreferrer noopener">Dogecoin Surges 14% In A Week: Is DOGE The Next Treasury Asset Boom? &#8211; Benzinga</a>
Why It Matters: Despite the concerns, Musk announced that Tesla&#8217;s Full Self-Driving system would see a &#8220;step change improvement&#8221; as the company <a href="https://www.benzinga.com/markets/tech/25/07/46511765/elon-musk-says-teslas-self-driving-tech-is-about-to-get-major-boost-from-austin-robotaxi-upgrades-step-change-improvement">integrates </a>Robotaxi upgrades into its production models.
Furthermore, Gary Black of Future Fund LLC had pointed out that Tesla holds a <a href="https://www.benzinga.com/markets/tech/25/06/46133153/tesla-robotaxi-has-a-major-advantage-over-rivals-waymo-and-zoox-says-gary-black-could-be-very-significant">significant advantage </a>over Robotaxi rivals such as Alphabet Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Waymo and Amazon.com Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Zoox. He emphasized that every Tesla robotaxi produced is ready for deployment right out of the factory. 
This development was expected to significantly enhance Tesla&#8217;s self-driving technology, but the recent safety concerns raise questions about the readiness of the technology for such a major upgrade.
Tesla has strong metrics on Momentum, Quality and Growth, but offers poor Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound" target="_blank" rel="noreferrer noopener">&nbsp;Benzinga Edge Stock Rankings</a>&nbsp;today!
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="789" height="124" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21033230/image-263.png" alt="" class="wp-image-993118" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21033230/image-263.png 789w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21033230/image-263-300x47.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/21033230/image-263-768x121.png 768w" sizes="(max-width: 789px) 100vw, 789px" /></figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/07/46510590/elon-musk-returns-to-intense-work-schedule-back-to-working-7-days-a-week-and-sleeping-in-the-office">Elon Musk Returns To Intense Work Schedule: &#8216;Back To Working 7 Days a Week and Sleeping in the Office</a></li>
</ul>
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AMZN

GOOG

GOOGL

TSLA

Elon Musk Is 'Gambling' With Robotaxi, Says Expert Casting Doubt On Its Scalability And Tech Prowess—'Distraction From The Declining Sales'

Taiwan Semiconductor Manufacturing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) plans to start construction on <a target="_blank" href="https://www.benzinga.com/topic/ai-chips" rel="noreferrer noopener">four new fabs</a> later this year, targeting mass production of 2-nanometer chips by late 2028, according to Central Taiwan Science Park Bureau Director-General Hsu Maw-shin.
The new facilities, designated Fab 25, will house four 1.4-nanometer wafer production lines. The contract chipmaker aims to complete risk assessments by 2027 and ramp up to a monthly output of 50,000 wafers, the Taipei Times <a target="_blank" href="https://www.taipeitimes.com/News/front/archives/2025/07/20/2003840583" rel="noreferrer noopener">reported</a> on Sunday.
Taiwan Semiconductor has already leased the land for the new fabs, with the Central Taiwan Science Park transferring the site last month. The park&#8217;s second-phase expansion will begin with soil and water conservation infrastructure, including detention ponds.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/07/46499511/taiwan-semiconductor-cfo-warns-of-margin-pressure-prudent-42-billion-capex-plan" rel="noreferrer noopener">Taiwan Semiconductor CFO Warns Of Margin Pressure, Prudent $42 Billion CapEx Plan</a>
Hsu projected that the park&#8217;s annual turnover will exceed 1.2 trillion New Taiwan dollars ($40.81 billion), setting a new record.
During Taiwan Semiconductor&#8217;s second-quarter earnings call, Chairman C.C. Wei disclosed that the company will allocate about 30% of its 2-nanometer and more advanced chip capacity to Arizona after completing its $165 billion U.S. investment. That investment includes six wafer fabs, two advanced packaging facilities, and a major R&amp;D center.
Wei also said Taiwan Semiconductor plans to build 11 wafer fabs and four advanced packaging facilities globally over the next few years. The company is preparing additional 2-nanometer fabs in Hsinchu and Kaohsiung to meet growing customer demand.
Taiwan Semiconductor closed with a market value above $1 trillion in Taipei for the first time last week, driven by a sharp rise in sales forecasts fueled by soaring demand for artificial intelligence chips.
The chipmaker&#8217;s shares surged to a record high on Friday, marking a nearly 50% gain since April and making it the first Asian stock to top the $1 trillion mark since PetroChina briefly did so in 2007, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-21/tsmc-joins-trillion-dollar-club-on-optimism-over-ai-demand?sref=TBDibEcD" rel="noreferrer noopener">reported</a> on Monday. The chipmaker is a key Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) supplier.
The company raised its full-year revenue growth outlook to around 30%, signaling strong positioning amid intensifying competition for AI chip production.
Goldman Sachs analysts, including Bruce Lu, observed that demand for Taiwan Semiconductor&#8217;s advanced nodes continues to grow steadily. They anticipate the company will introduce more significant price increases in 2026 as AI-driven orders remain strong.
Price Action:&nbsp;TSM stock is trading higher by 0.37% to $241.29 premarket at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46501869/meta-raids-apples-ai-lab-with-big-paychecks-zuckerberg-bets-to-win-the-ai-race" target="_blank" rel="noreferrer noopener">Meta Raids Apple&#8217;s AI Lab With Big Paychecks—Zuckerberg Bets To Win The AI Race</a></li>
</ul>
Photo by Jack Hong via Shutterstock

Tech

Media

AAPL

NVDA

Taiwan Semiconductor Plans Four New Fabs As AI Gold Rush Continues

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Marsh &amp; McLennan Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMC#NYSE">MMC</a>) with a Underperform and lowers the price target from $214 to $210.

Keefe, Bruyette & Woods Maintains Underperform on Marsh & McLennan Cos, Lowers Price Target to $210

Jefferies analyst John Hecht initiates coverage on Jefferson Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JCAP#NASDAQ">JCAP</a>) with a Buy rating and announces Price Target of $29.

JCAP

Jefferies Initiates Coverage On Jefferson Capital with Buy Rating, Announces Price Target of $29

Parsons Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSN#NYSE">PSN</a>), a leader in technology-driven solutions, is proud to announce the development of BlueFly&#x2122;, an innovative search and rescue sensor that enhances the capabilities of emergency response teams. Designed with state-of-the-art technology and affordability in mind, BlueFly&#x2122;&nbsp;aims to revolutionize how agencies conduct search and rescue missions in challenging and remote environments.
Developed by QRC&#xAE;, a Parsons Company, the BlueFly&#x2122;&nbsp;platform leverages the latest advancements in Bluetooth low-energy detection to provide real-time situational awareness support for drone operator first responders. This comprehensive solution accelerates search operations and dramatically improves the probability of survival and outcomes.

Parsons Unveils BlueFly Search Sensor to Boost Drone-Assisted Rescue Missions in Remote Areas

Iron ore prices have rebounded above $100 for the first time since February. Renewed optimism about China's economic resilience and the announcement of construction of the world's largest hydropower dam drove momentum of the futures market in Singapore.
Yet, some analysts believe the rally is unsustainable given the market dynamics and healthy <a target="_blank" href="https://www.benzinga.com/topic/iron-ore" rel="noreferrer noopener">capacity increases from key producers</a>.
In a note cited <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-07-16/iron-ore-tops-100-for-first-time-since-may-on-china-sentiment" rel="noreferrer noopener">by</a> Bloomberg, Citi strategists, including Shreyas Madabushi, warned that "prices are currently above market fundamentals," suggesting a more modest and gradual decline in steel output rather than an aggressive contraction.
Meanwhile, Rio Tinto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) has fast-tracked its timeline for shipments from the massive Simandou iron ore mine in Guinea. The firm expects to ship 0.5 to 1 million tons this November.
While the monumental project could deliver as much as 120 million tons annually, the ramp-up should remain gradual.
RBC analysts forecast output will reach just 12 million tons in 2026 and not top 48 million until 2028.
RIO's rival BHP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>) reported a 14% quarter-on-quarter jump in Q4 iron ore production to 70.3 million tons, helping push annual output to a record 290 million tons.
While oversupply looms, official Chinese economic data indicate strong demand, further supported by Premier Li Quiang's Monday announcement.
Quiang broke news on construction of the world's largest hydropower dam on the Yarlung Tsangpo River. The dam, which is expected to exceed the Three Gorges Dam by at least a factor of three, is expected to drive significant demand for construction-grade steel.
Per China Briefing's <a target="_blank" href="https://www.china-briefing.com/news/chinas-economy-in-h1-2025-gdp-trade-and-fdi-highlights/" rel="noreferrer noopener">report</a>, GDP rose 5.3% year-on-year in the first half of 2025, with industrial output up 6.4%, services growing 5.5%, and retail sales up 5.0%. Fixed asset investment rose 2.8%, led by manufacturing, and disposable income grew 5.4% in real terms. National Bureau of Statistics Deputy Head Sheng Laiyun called the results a "hard-won achievement" amid global volatility.
Former Australian Ambassador to China Geoff Raby noted that Prime Minister Anthony Albanese's latest visit to China provides an opportunity.
"Although China's growth in demand for Australian iron ore is tapering off, the absolute volume we sell is so large that even a small uptick in demand will lead to tremendous increases in volume," Raby <a target="_blank" href="https://www.youtube.com/watch?v=VuBsZheeGB8" rel="noreferrer noopener">told</a> ABC. "It's a two-way relationship," he added, arguing that China's pivot to green steel is not a threat, but a future opportunity for Australian producers.
"We have massive potential in terms of renewable energy. Ross Garnaut has written about this on numerous occasions in books, and he talks about Australia being the energy superpower of the future because of this very reason."
Raby also clarified that Australia must balance its engagement with China against global pressures, especially from the U.S.
"The Prime Minister has stuck to our strong commitment to free trade, and has not gone down the path of retaliatory tariffs. So, I think that puts us in a very strong position," he said.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/node/46438534" target="_blank" rel="noreferrer noopener">Three Factors Keeping Gold's Momentum In 2025: Report</a></li>
</ul>
Photo by saweang.w via Shutterstock

Asia

Politics

Global

China-Led Rally Sends Iron Ore Over $100 Despite Looming Oversupply

TD Cowen analyst Bill Katz upgrades Invesco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVZ#NYSE">IVZ</a>) from Hold to Buy and raises the price target from $17.5 to $25.

Upgrades

TD Cowen Upgrades Invesco to Buy, Raises Price Target to $25

Trading Halt: Halted at 6:20:03 a.m. ET - Trading Halt: Halt News Pending

Earnings

Domino's Pizza Reported 5.6% Global Retail Sales Increase Backed By 148 International And 30 US Store Openings

Domino's Pizza's Same Store Sales Rise 3.4% In US And 2.4% Internationally, Ex-FX

Keefe, Bruyette &amp; Woods analyst Christopher Mcgratty maintains Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Outperform and raises the price target from $69 to $73.

Keefe, Bruyette & Woods Maintains Outperform on Comerica, Raises Price Target to $73

GigaMedia Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) today announced that the Company has entered into and executed an agreement to purchase a US$1,500,000 principal amount of convertible promissory note (the "Note") issued by Aeolus Robotics Corporation ("Aeolus"), a global company primarily engaged in designing, manufacturing, processing and sales of intellectual robotics.
&nbsp;
The Note, bearing interest at a rate of 4.5% per annum, shall be due in 36 months, and all or a portion of the principal amount under the Note may be convertible at GigaMedia's option upon maturity, upon prepayment, or when certain events occur, into ordinary shares of Aeolus at a price of US$0.02 per share.
&nbsp;
The purchase and sale of the Note exhibits GigaMedia and Aeolus's mutual commitment to a longer-term strategic relationship. GigaMedia continually reviews its investment alternatives and may enter into additional transactions of Aeolus's securities in accordance with applicable laws.

Comments

Baird Medical Investment

Interés en corto

Baird Medical Investment (NASDAQ:BDMD) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL